[go: up one dir, main page]

EE200000212A - Sferoidi südamik ja selle valmistamismeetod, sferoid, terapeutiline sferoid, kapseldatud, pikendatud toimeajaga ravimvorm ja meetod venlafaksiinvesinikkloriidi sisaldavate sferoidide südamike valmistamiseks - Google Patents

Sferoidi südamik ja selle valmistamismeetod, sferoid, terapeutiline sferoid, kapseldatud, pikendatud toimeajaga ravimvorm ja meetod venlafaksiinvesinikkloriidi sisaldavate sferoidide südamike valmistamiseks

Info

Publication number
EE200000212A
EE200000212A EEP200000212A EEP200000212A EE200000212A EE 200000212 A EE200000212 A EE 200000212A EE P200000212 A EEP200000212 A EE P200000212A EE P200000212 A EEP200000212 A EE P200000212A EE 200000212 A EE200000212 A EE 200000212A
Authority
EE
Estonia
Prior art keywords
spheroid
preparation
therapeutic
release formulation
core
Prior art date
Application number
EEP200000212A
Other languages
English (en)
Inventor
Marie Sherman Deborah
Clifton Clark John
Ulrick Lamer John
Original Assignee
American Home Products Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25508423&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE200000212(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by American Home Products Corporation filed Critical American Home Products Corporation
Publication of EE200000212A publication Critical patent/EE200000212A/et
Publication of EE04577B1 publication Critical patent/EE04577B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EEP200000212A 1997-11-05 1998-11-03 Sferoidi südamik ja selle valmistamismeetod, sferoid ja kapseldatud, pikendatud toimeajaga ravimvorm EE04577B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96432897A 1997-11-05 1997-11-05
PCT/US1998/023338 WO1999022724A2 (en) 1997-11-05 1998-11-03 Extended release formulation containing venlafaxin

Publications (2)

Publication Number Publication Date
EE200000212A true EE200000212A (et) 2001-04-16
EE04577B1 EE04577B1 (et) 2006-02-15

Family

ID=25508423

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000212A EE04577B1 (et) 1997-11-05 1998-11-03 Sferoidi südamik ja selle valmistamismeetod, sferoid ja kapseldatud, pikendatud toimeajaga ravimvorm

Country Status (38)

Country Link
EP (1) EP1028718B1 (et)
JP (1) JP2001521892A (et)
KR (1) KR20010031797A (et)
CN (1) CN1278165A (et)
AR (1) AR014012A1 (et)
AT (1) ATE237320T1 (et)
AU (1) AU747978B2 (et)
BG (1) BG104397A (et)
BR (1) BR9813179A (et)
CA (1) CA2305242A1 (et)
CL (1) CL2004001705A1 (et)
CO (1) CO5011060A1 (et)
CZ (1) CZ20001659A3 (et)
DE (1) DE69813602T2 (et)
DK (1) DK1028718T3 (et)
EA (1) EA200000487A1 (et)
EE (1) EE04577B1 (et)
ES (1) ES2196620T3 (et)
GE (1) GEP20043198B (et)
HR (1) HRP20000213B1 (et)
HU (1) HU225238B1 (et)
ID (1) ID26317A (et)
IL (1) IL135457A0 (et)
MA (1) MA24691A1 (et)
NO (1) NO20002126L (et)
NZ (1) NZ504460A (et)
PA (1) PA8462501A1 (et)
PE (1) PE128699A1 (et)
PL (1) PL341141A1 (et)
PT (1) PT1028718E (et)
SK (1) SK6472000A3 (et)
SV (1) SV1998000131A (et)
TR (1) TR200001232T2 (et)
TW (1) TW555568B (et)
UA (1) UA77145C2 (et)
UY (2) UY25234A1 (et)
WO (1) WO1999022724A2 (et)
ZA (1) ZA9810081B (et)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0200898A3 (en) * 1999-04-06 2005-09-28 Sepracor Inc Derivatives of venlafaxine and methods of preparing and using the same
RU2275191C2 (ru) * 1999-05-20 2006-04-27 Элан Корпорейшн, Плс Состоящие из множества частиц фармацевтические составы с контролируемым высвобождением избирательного ингибитора повторного поглощения серотонина
IL146462A (en) * 2001-11-13 2015-02-26 Lycored Bio Ltd Prolonged-release preparations containing as an active compound and analapaxin hydrochloride
RU2004120285A (ru) * 2001-12-05 2005-04-10 Уайт (Us) Новый кристаллический полиморф гидрохлорида венлафаксина и способы его получения
WO2003050074A1 (en) * 2001-12-13 2003-06-19 Cadila Healthcare Limited Manufacture of venlafaxine hydrochloride and crystalline polymorphs thereof
WO2003055475A1 (en) * 2002-01-03 2003-07-10 Lek Pharmaceutical And Chemical Company D.D. Controlled release pharmaceutical formulation containing venlafaxine
AU2003221535A1 (en) 2002-03-28 2003-10-13 Synthon B.V. Venlafaxine besylate
AU2003226748A1 (en) * 2002-03-28 2003-10-13 Synthon B.V. Compositions of venlafaxine base
AU2003226751A1 (en) 2002-03-28 2003-10-13 Synthon B.V. Low water-soluble venlafaxine salts
US20030190351A1 (en) * 2002-03-28 2003-10-09 Synthon Bv Extended release venlafaxine formulations
FR2845289B1 (fr) 2002-10-04 2004-12-03 Ethypharm Sa Spheroides, procede de preparation et compositions pharmaceutiques.
CA2415154C (en) * 2002-12-24 2009-06-16 Biovail Laboratories Inc. Modified release formulations of selective serotonin re-uptake inhibitors
DE10350194B4 (de) * 2003-10-28 2005-11-10 Bioplanta Arzneimittel Gmbh Verwendung von Extrakten aus Opuntien zur Behandlung von depressiven Verstimmungen und Erkrankungen
TW200503670A (en) * 2003-03-28 2005-02-01 Sandoz Ag Venlafaxine compositions
EP1502587B1 (en) * 2003-07-30 2006-08-23 Pharmathen S.A. Sustained release formulation for Venlafaxine hydrochloride
HUP0303382A2 (hu) * 2003-10-10 2005-08-29 EGIS Gyógyszergyár Rt. Venlafaxin-hidroklorid-tartalmú pelletek
EP1711169B1 (en) 2004-02-04 2007-05-09 Alembic Limited Extended release coated minitablets of venlafaxine hydrochloride
US7776358B2 (en) 2004-07-22 2010-08-17 Synthon Ip Inc. Extended release venlafaxine besylate tablets
EP2010162A4 (en) * 2006-04-03 2013-01-09 Isa Odidi COMPOSITION FOR DISPOSING A MEDICINAL PRODUCT
WO2007129329A2 (en) * 2006-05-08 2007-11-15 Jubilant Organosys Limited Extended release pharmaceutical formulation comprising venlafaxine hydrochloride
CN102772390B (zh) * 2012-08-16 2014-01-08 乐普药业股份有限公司 一种盐酸文拉法辛缓释胶囊及其制备方法
FR3080278B1 (fr) * 2018-04-11 2021-04-30 Ghs Patents Ltd Procede de fabrication d'un spheroide de cannabidiol

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
PE57198A1 (es) * 1996-03-25 1998-10-10 American Home Prod Formula de liberacion prolongada
ZA97976B (en) * 1996-04-05 1997-08-18 Alza Corp Uniform drug delivery theraphy.

Also Published As

Publication number Publication date
HRP20000213A2 (en) 2000-12-31
HUP0004287A3 (en) 2002-05-28
HK1029056A1 (en) 2001-03-23
CL2004001705A1 (es) 2005-06-03
BR9813179A (pt) 2000-08-22
CN1278165A (zh) 2000-12-27
KR20010031797A (ko) 2001-04-16
ES2196620T3 (es) 2003-12-16
WO1999022724A2 (en) 1999-05-14
AU747978B2 (en) 2002-05-30
PE128699A1 (es) 2000-01-06
EP1028718A2 (en) 2000-08-23
BG104397A (en) 2001-02-28
PL341141A1 (en) 2001-03-26
TR200001232T2 (tr) 2000-12-21
ATE237320T1 (de) 2003-05-15
DK1028718T3 (da) 2003-07-28
UY25234A1 (es) 2000-12-29
HRP20000213B1 (en) 2004-04-30
HU225238B1 (en) 2006-08-28
UA77145C2 (en) 2006-11-15
HUP0004287A2 (hu) 2002-04-29
NO20002126D0 (no) 2000-04-26
GEP20043198B (en) 2004-03-25
UY25692A1 (es) 2000-03-31
TW555568B (en) 2003-10-01
NO20002126L (no) 2000-05-04
AR014012A1 (es) 2001-01-31
EA200000487A1 (ru) 2000-10-30
DE69813602T2 (de) 2003-11-06
ZA9810081B (en) 2000-05-04
PA8462501A1 (es) 2000-05-24
CO5011060A1 (es) 2001-02-28
DE69813602D1 (de) 2003-05-22
EP1028718B1 (en) 2003-04-16
IL135457A0 (en) 2001-05-20
NZ504460A (en) 2003-01-31
SK6472000A3 (en) 2000-11-07
ID26317A (id) 2000-12-14
PT1028718E (pt) 2003-07-31
CA2305242A1 (en) 1999-05-14
CZ20001659A3 (cs) 2001-10-17
WO1999022724A3 (en) 1999-07-22
SV1998000131A (es) 1999-11-18
MA24691A1 (fr) 1999-07-01
AU1300399A (en) 1999-05-24
EE04577B1 (et) 2006-02-15
JP2001521892A (ja) 2001-11-13

Similar Documents

Publication Publication Date Title
EE200000212A (et) Sferoidi südamik ja selle valmistamismeetod, sferoid, terapeutiline sferoid, kapseldatud, pikendatud toimeajaga ravimvorm ja meetod venlafaksiinvesinikkloriidi sisaldavate sferoidide südamike valmistamiseks
FI962917A7 (fi) Mikrokapselit, menetelmä niiden valmistamiseksi, ja niiden käyttö
NO20006633D0 (no) Preparat som omfatter <beta>-hydroksy-<beta>-metylsmörsyre og minst én aminosyre, og fremgangsmåter for anvendelse
BR9710858A (pt) Agente de liga-Æo para nÚcleos e moldes
NO973612L (no) Nytt farmasöytisk preparat
EE9700328A (et) Tahke oraalne preparaat, mis sisaldab toimeainena olansapiini, selle valmistamismeetod ja kasutamine
FI980023L (fi) Sienilääke, siihen soveltuva yhdiste, menetelmä niiden valmistamiseksi ja menetelmä niiden käyttämiseksi
DE60024988D1 (de) Herstellung von therapeutischem mikroschaum
FI971967L (fi) Dioksomorfoliinien käyttö sisäloisten torjuntaan, uusia dioksomorfiineja ja menetelmä niiden valmistamiseksi
IL120382A0 (en) Extended release formulation of venlafaxine hydrochloride
NO975831L (no) Nytt farmasöytisk preparat med anestetisk virkning
NO963032L (no) Oralt preparat
HUP0102371A3 (en) Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors process for their preparation and medicament and device comprising them
NO984878D0 (no) Fremstilling og anvendelse som medikamenter av 3-alkoksypyridin-2-karboksylsyreamidestere
EE04490B1 (et) Ühend, selle valmistamise meetod ning kasutamine meditsiinis
DE50112123D1 (de) Retard-zubereitungen von chinolon-antibiotika und verfahren zu ihrer herstellung
NO975037L (no) Preparat omfattende amoxycillin og clavulansyre
EE200100383A (et) L-fenüülefriinvesinikkloriidi valmistamise meetod
NO942303D0 (no) Farmasöytisk preparat, samt fremgangsmåte for fremstilling derav
FI951631A7 (fi) Substituoituja kynureniinejä, menetelmä niiden valmistamiseksi ja niid en käyttö lääkkeinä
NO975076L (no) Farmasöytisk preparat som inneholder tiagabinhydroklorid, og fremgangsmåte for dets fremstilling
EE03387B1 (et) Kombineeritud ravimpreparaat, selle kasutamine ja meetod selle valmistamiseks
NO973610D0 (no) Nytt farmasöytisk preparat
BR9505995A (pt) Composto método para tratamentos e composição farmacêutica
DE69420876D1 (de) Liposom mit eingekapseltem Hämoglobin sowie Verfahren zu dessen Herstellung

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

MM4A Lapsed by not paying the annual fees

Effective date: 20071103